NCT04394975
- Conditions
- Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1
- Locations
-
- Beijing Cancer Hospital Beijing, China
Clinical trial condition
Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1
Explore clinical trials studying Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies